1 / 5

India Pharmaceuticals and Healthcare Report in India

Market reports on India presents the latest report on “India Pharmaceuticals and Health care Report in India” http://www.marketreportsonindia.com/life-sciences-market-research-reports-1/india-pharmaceuticals-and-healthcare-report.html Forecast broadly in line with Q313, although growth in US<br>dollar terms was impacted by the depreciation of the rupee.

SophiaJones
Télécharger la présentation

India Pharmaceuticals and Healthcare Report in India

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. India Pharmaceuticals and Healthcare Report in India Market Reports On India Market Reports On India By: http://www.marketreportsonindia.com/

  2. Summary • Pharmaceutical firms continue to post varying results in India due to the government's • introduction of policies targeting the pharmaceutical industry. These include patent disrespect and pricecontainment • policies for both generic and patented drugs. We maintain our bearish view on the sector and • highlight that domestic firms with a large exposure to overseas markets will continue to fare well. • Headline Expenditure Projections Contact No: +91.22.27810772/ 73 Email Id : info@marketreportsonindia.com

  3. Pharmaceuticals: INR840.0bn (US$15.7bn) in 2012 to INR921.2bn (US$16.5bn) in 2013; +9.7% in local currency terms and +4.6% in US dollar terms. Forecast broadly in line with Q313, although growth in US dollar terms was impacted by the depreciation of the rupee. Healthcare: INR3,811.2bn (US$71.3bn) in 2012 to INR4,209.7bn (US$75.2bn) in 2013; +10.5% in local currency terms and 5.4% in US dollar terms. Forecast broadly in line with Q313, although growth in US dollar terms was impacted by the depreciation of the rupee. Contact No: +91.22.27810772/ 73 Email Id : info@marketreportsonindia.com

  4. Table of Contents Industry View Table: Commercial Banking Sector Indicators Table: Commercial Banking Key Ratios, April 2013 Table: Annual Growth Rate Projections, 2012-2017 (%) Table: Ranking Out Of 69 Countries Reviewed In 2013 Table: Commercial Banking Sector Indicators, 2010-2017 SWOT Commercial Banking Political Economic Business Environment Industry Forecast Contact No: +91.22.27810772/ 73 Email Id : info@marketreportsonindia.com

  5. To view the full Executive Summary and Table of Contents, please visit India Pharmaceuticals and Healthcare Report in India Contact us : Market Reports on IndiaPhone no:+912227810772 / 73E-mail to: info@marketreportsonindia.comWebsite: https://www.marketreportsonindia.com

More Related